Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Clears Dexcom’s 15-Day CGM System for Adult Diabetes Management
FDA Clears Dexcom’s 15-Day CGM System for Adult Diabetes Management
FDA Clears Dexcom’s 15-Day CGM System for Adult Diabetes Management
Submitted by
admin
on April 10, 2025 - 10:01pm
Source:
Medical Devices and Diagnostics Industry
News Tags:
DexCom
Medtech
CGMs
diabetes
G7
Headline:
FDA Clears Dexcom’s 15-Day CGM System for Adult Diabetes Management
snippet:
Dexcom G7 15-Day CGM boasts 8.0% MARD.
The CGM is set to launch in the second half of 2025.
Dexcom G7 15 Day CGM competes with Abbott's Libre.
Do Not Allow Advertisers to Use My Personal information
